Coyne Terrance P.
EVP & CFO
CIK: 1814876
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | Royalty Pharma plc (RPRX) | S | 32,916 | $49.78 | $1,638,505.81 | View Details Filing |
| Apr 28, 2026 | Royalty Pharma plc (RPRX) | S | 1,875 | $49.78 | $93,334.50 | View Details Filing |
| Apr 1, 2026 | Royalty Pharma plc (RPRX) | S | 32,916 | $48.33 | $1,590,889.53 | View Details Filing |
| Apr 1, 2026 | Royalty Pharma plc (RPRX) | S | 1,875 | $48.33 | $90,622.12 | View Details Filing |
| Mar 23, 2026 | Royalty Pharma plc (RPRX) | S | 1,875 | $45.53 | $85,366.31 | View Details Filing |
| Mar 23, 2026 | Royalty Pharma plc (RPRX) | S | 32,916 | $45.53 | $1,498,622.69 | View Details Filing |
| Mar 2, 2026 | Royalty Pharma plc (RPRX) | S | 1,292 | $46.67 | $60,303.71 | View Details Filing |
| Mar 2, 2026 | Royalty Pharma plc (RPRX) | S | 10,429 | $47.01 | $490,314.22 | View Details Filing |
| Mar 2, 2026 | Royalty Pharma plc (RPRX) | S | 22,487 | $46.67 | $1,049,506.52 | View Details Filing |
| Mar 2, 2026 | Royalty Pharma plc (RPRX) | S | 583 | $47.01 | $27,409.34 | View Details Filing |
| Feb 23, 2026 | Royalty Pharma plc (RPRX) | S | 1,875 | $45.32 | $84,968.44 | View Details Filing |
| Feb 23, 2026 | Royalty Pharma plc (RPRX) | S | 32,916 | $45.32 | $1,491,637.91 | View Details Filing |